ARCHIVES

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

December 17, 2010

AACI Developing Suggestions Or New Cancer Control Grant Guidelines

July 20, 1979

Letter to the Editor

February 21, 2003

Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk

January 31, 2014

NCAB To Seek Changes In Cancer Act Renewal, Budget Improvements

November 20, 1987

Henry Brem Named Director Of Neurology At Johns Hopkins.

July 28, 2000